Rockefeller Capital Management L.P. Cellectis S.A. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.01 - $12.84 $8,674 - $13,905	-1,083 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$18.19 - $33.25 $17,698 - $32,352	973 Added 884.55%	1,083 $21,000
Q4 2020 Feb 12, 2021	SELL	$15.87 - $31.64 $460 - $917	-29 Reduced 20.86%	110 $2,000
Q3 2020 Nov 13, 2020	BUY	$15.7 - $20.84 $2,182 - $2,896	139 New	139 $2,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.